This inventor holds 18 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Isoprenoid Production. Top assignees: University of California, Amyris Biotechnologies, Inc., Amyris, Inc.. Active years: 2007-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Francisco, CA (US) (2007 - 2012)
- Berkeley, CA (US) (2007 - 2018)
Company Filing History:
14 out of 16,058 
3 out of 18 
2 out of 105 
Years Active: 2007-2018
Areas of Expertise:
Title: **Innovative Contributions of Inventor Jack Newman**
Introduction
Jack Newman, an accomplished inventor based in Berkeley, California, has made significant contributions to the field of biotechnology, particularly in the production of isoprenoids. With a total of 18 patents to his name, he continues to influence research and development in the industry.
Latest Patents
One of Jack Newman's latest patents revolves around innovative methods for producing isoprenoids. This patent details the use of a plurality of bacterial or fungal host cells that incorporate a heterologous nucleic acid encoding key enzymes in the mevalonate pathway, which is essential for the synthesis of isopentenyl pyrophosphate. The patent outlines the enzymatic processes involved, including the condensation of acetoacetyl-CoA with acetyl-CoA to form HMG-CoA, as well as various other enzymatic conversions leading to the final production of isopentenyl pyrophosphate. Notably, the host cells are cultured under suboptimal conditions to enhance isoprenoid yield, which showcases Newman's innovative approach to optimizing bioproduction.
Career Highlights
Jack Newman has held pivotal roles in respected institutions, including the University of California, where he has contributed to cutting-edge research in biotechnology. His tenure at Amyris Biotechnologies, Inc. is also notable, reflecting his commitment to advancing biotechnological applications.
Collaborations
Throughout his career, Newman has collaborated with esteemed colleagues such as Jay D. Keasling and Douglas J. Pitera. These partnerships exemplify the collaborative spirit in scientific research, contributing to innovative breakthroughs in the production of biochemicals.
Conclusion
Jack Newman stands out as a significant innovator in the field of biotechnology with his extensive patent portfolio and impactful collaborations. His work not only advances the knowledge in isoprenoid production but also sets the groundwork for future innovations in the area, underlining the critical role that inventors play in scientific and technological progress.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile